(MATV) Mativ Holdings - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 472m USD | Total Return: 57.5% in 12m
Avg Turnover: 3.34M
EPS Trend: -71.2%
Qual. Beats: 0
Rev. Trend: -68.3%
Qual. Beats: 0
Warnings
High Debt/EBITDA (5.5) with thin interest coverage (0.8)
Interest Coverage Ratio 0.8 is critical
Altman Z'' 0.88 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Mativ Holdings, Inc. (MATV) is a global manufacturer of specialty materials, formed through the 2022 merger of Schweitzer-Mauduit International and Neenah, Inc. The company operates via two primary segments: Filtration & Advanced Materials and Sustainable & Adhesive Solutions. Its product portfolio includes engineered polymers, resins, fiber-based substrates, and specialty papers used across diverse end-markets such as healthcare, construction, and transportation.
The company utilizes a business model focused on material science and technical engineering to produce high-margin, niche components. In the specialty paper and nonwovens sector, profitability is often driven by the ability to customize fiber-based solutions for specific industrial applications, such as high-performance air filtration or medical-grade wound care. This diversification helps mitigate cyclicality in any single consumer or industrial category.
To better understand the companys valuation and market position, you may find it useful to explore the analytical tools available on ValueRay. Mativ Holdings is headquartered in Alpharetta, Georgia, and serves a broad international customer base spanning North America, Europe, and the Asia Pacific region.
- Industrial demand for filtration and protective films dictates top-line revenue growth
- Raw material price volatility impacts margins for specialty paper and polymers
- Global construction and infrastructure spending cycles drive adhesive tape sales volume
- Portfolio restructuring and debt deleveraging efforts influence long-term equity valuation
- Shift toward sustainable packaging alternatives expands market share in consumer goods segment
| Net Income: 76.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.03 > 1.0 |
| NWC/Revenue: 18.71% < 20% (prev 20.25%; Δ -1.54% < -1%) |
| CFO/TA 0.07 > 3% & CFO 150.7m > Net Income 76.4m |
| Net Debt (1.07b) to EBITDA (192.5m): 5.55 < 3 |
| Current Ratio: 2.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.8m) vs 12m ago 0.70% < -2% |
| Gross Margin: 17.32% > 18% (prev 0.18%; Δ 1.71k% > 0.5%) |
| Asset Turnover: 96.98% > 50% (prev 95.78%; Δ 1.20% > 0%) |
| Interest Coverage Ratio: 0.76 > 6 (EBITDA TTM 192.5m / Interest Expense TTM 67.5m) |
| A: 0.18 (Total Current Assets 664.9m - Total Current Liabilities 294.1m) / Total Assets 2.03b |
| B: -0.10 (Retained Earnings -213.2m / Total Assets 2.03b) |
| C: 0.02 (EBIT TTM 51.0m / Avg Total Assets 2.04b) |
| D: -0.14 (Book Value of Equity -212.6m / Total Liabilities 1.56b) |
| Altman-Z'' = 0.88 = B |
| DSRI: 0.91 (Receivables 202.8m/221.1m, Revenue 1.98b/1.97b) |
| GMI: 1.04 (GM 17.32% / 17.94%) |
| AQI: 1.04 (AQ_t 0.35 / AQ_t-1 0.33) |
| SGI: 1.01 (Revenue 1.98b / 1.97b) |
| TATA: -0.04 (NI 76.4m - CFO 150.7m) / TA 2.03b) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 8.57 with a total of 256,329 shares traded.
Over the past week, the price has changed by +6.72%,
over one month by -9.80%,
over three months by -19.52% and
over the past year by +57.54%.
Mativ Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy MATV.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21 | 145% |
P/E Forward = 9.5329
P/S = 0.2381
P/B = 0.9453
P/EG = 3.5625
Revenue TTM = 1.98b USD
EBIT TTM = 51.0m USD
EBITDA TTM = 192.5m USD
Long Term Debt = 1.03b USD (from longTermDebt, last quarter)
Short Term Debt = 2.90m USD (from shortLongTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter) + Leases 63.1m
Net Debt = 1.07b USD (calculated: Debt 1.15b - CCE 82.3m)
Enterprise Value = 1.54b USD (471.8m + Debt 1.15b - CCE 82.3m)
Interest Coverage Ratio = 0.76 (Ebit TTM 51.0m / Interest Expense TTM 67.5m)
EV/FCF = 13.25x (Enterprise Value 1.54b / FCF TTM 116.2m)
FCF Yield = 7.55% (FCF TTM 116.2m / Enterprise Value 1.54b)
FCF Margin = 5.86% (FCF TTM 116.2m / Revenue TTM 1.98b)
Net Margin = 3.86% (Net Income TTM 76.4m / Revenue TTM 1.98b)
Gross Margin = 17.32% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.64b) / Revenue TTM)
Gross Margin QoQ = 14.37% (prev 15.40%)
Tobins Q-Ratio = 0.76 (Enterprise Value 1.54b / Total Assets 2.03b)
Interest Expense / Debt = 5.87% (Interest Expense 67.5m / Debt 1.15b)
Taxrate = 21.0% (US default 21%)
NOPAT = 40.3m (EBIT 51.0m * (1 - 21.00%))
Current Ratio = 2.26 (Total Current Assets 664.9m / Total Current Liabilities 294.1m)
Debt / Equity = 2.43 (Debt 1.15b / totalStockholderEquity, last quarter 472.3m)
Debt / EBITDA = 5.55 (Net Debt 1.07b / EBITDA 192.5m)
Debt / FCF = 9.19 (Net Debt 1.07b / FCF TTM 116.2m)
Total Stockholder Equity = 446.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.74% (Net Income 76.4m / Total Assets 2.03b)
RoE = 11.59% (Net Income TTM 76.4m / Total Stockholder Equity 659.5m)
RoCE = 3.01% (EBIT 51.0m / Capital Employed (Equity 659.5m + L.T.Debt 1.03b))
RoIC = 2.41% (NOPAT 40.3m / Invested Capital 1.67b)
WACC = 7.64% (E(471.8m)/V(1.62b) * Re(14.97%) + D(1.15b)/V(1.62b) * Rd(5.87%) * (1-Tc(0.21)))
Discount Rate = 14.97% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 73.33 | Cagr: 0.27%
[DCF] Terminal Value 77.97% ; FCFF base≈83.6m ; Y1≈95.8m ; Y5≈141.0m
[DCF] Fair Price = 19.12 (EV 2.12b - Net Debt 1.07b = Equity 1.05b / Shares 55.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -71.19 | EPS CAGR: -30.17% | SUE: 0.37 | # QB: 0
Revenue Correlation: -68.28 | Revenue CAGR: -3.86% | SUE: -0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.28 | Chg30d=-17.65% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.34 | Chg30d=-10.53% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=0.85 | Chg30d=-10.99% | Revisions=-33% | GrowthEPS=+21.4% | GrowthRev=+1.2%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=-0.79% | Revisions=-20% | GrowthEPS=+47.1% | GrowthRev=+3.2%